PATENT CLAIM ANALYSIS

Application Number: 16150759
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "352000"]

Abstract:
A topical pharmaceutical preparation for administering a slightly soluble PDE4 inhibitor is described. A surprisingly good systemic bioavailability is observed with this dosage form.

Claim (Index 19):
The topically applicable pharmaceutical preparation of  claim 18 , wherein the active pharmaceutical ingredient is roflumilast, having the formula I: in which R1 is difluoromethoxy; R2 is cyclopropylmethoxy; and R3 is 3,5-dichloropyrid-4-yl.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11885837', '11662887', '10505138', '13008842', '15848505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7305788065568875
- 35 USC 102 Novelty (BERT): 0.4856964562539505
- Combined Prediction Score: 0.7060905715265937
- Mean Citation Score: 157.52345
- Max Citation Score: 179.21704
- Similarity Product: 127.6911753320122

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test